View in EDS HTML Full Text PDF Full Text

Feasibility trial of Darwin OncoTreat and OncoTarget precision medicine testing to improve outcomes for patients with limited metastatic disease that failed first-line systemic therapy.

Saved in:

Bibliographic Details
Title:	Feasibility trial of Darwin OncoTreat and OncoTarget precision medicine testing to improve outcomes for patients with limited metastatic disease that failed first-line systemic therapy.
Authors:	Radigan, Rachel^1,2 (AUTHOR) rradigan@nyit.edu, Sangal, Ashish³ (AUTHOR), Zhang, Dong² (AUTHOR), Weber, Jonathan⁴ (AUTHOR), Schmalzle, Megha^1,2 (AUTHOR), Finkelstein, Alexa² (AUTHOR), Duggal, Vaibhav² (AUTHOR), Kao, Johnny^1,2,3 (AUTHOR)
Source:	PLoS ONE. 6/11/2025, Vol. 20 Issue 6, p1-10. 10p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	19326203
DOI:	10.1371/journal.pone.0325769